Advances in polycythemia vera treatment with targeted therapies and clinical trials

Abstract Polycythemia vera (PV) is a chronic myeloproliferative disorder characterized by excessive red blood cell production, leading to a heightened risk of thrombosis, hemorrhage, and progression to myelofibrosis. While traditional therapies such as phlebotomy and hydroxyurea have been used for d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Doaa Hassanien, Rashid A. AlYafei, Omar H. Metwally, Izzaldin Alremawi, Abdulla Khalid Al-Kaabi, Mohamed Elahtem, Talal AL-Sayed, Mohamed A. Yassin
Formato: Artigo
Idioma:Inglês
Publicado em: Springer 2025-10-01
Colecção:Discover Oncology
Assuntos:
Polycythemia vera (PV)
Chronic myeloproliferative disorder (CMD)
Hepcidin agonists
MDM2 inhibitors
Histone deacetylase (HDAC) inhibitors
LSD1 inhibitors
Acesso em linha:https://doi.org/10.1007/s12672-025-03703-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados